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CBP/p300 Integrates Raf/Rac-Signaling Pathways
in the Transcriptional Induction of NF-ATc
during T Cell Activation
Ser/Thr-phosphatase. Calcineurin binds to NF-AT factors
in the 59 region adjacent to the RSD and, by dephosphor-
ylating several phospho-Ser/Thr residues, mediates the
nuclear transport of NF-AT factors, which, on the other
hand, is inhibited by the activity of one or several consti-
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1997; Zhu et al., 1998). Due to the common binding withInstitute of Pathology
immunophilins and inhibition of calcineurin, the immu-² Institute of Medical Radiation Research
nosuppressants cyclosporin A and FK506 are potentand Cell Biology
inhibitors of nuclear translocation and activity of all fourUniversity of Wuerzburg
NF-AT factors (Rao et al., 1997).D-97080 Wuerzburg
In addition to nuclear translocation, calcineurin alsoGermany
appears to control DNA binding of NF-AT factors. Whereas³Wellcome/CRC Institute and Department of Pathology
hyperphosphorylation was shown to inhibit DNA bindingUniversity of Cambridge
of NF-ATp, dephosphorylation by calcineurin (or otherCambridge CB2 1QR
phosphatases) strongly stimulated the binding of NF-United Kingdom
ATp to DNA (Park et al., 1995). A further level at which
the activity of NF-AT factors might be controlled is the
level of transactivation. Inducible transactivation do-Summary
mains (TADs) have been identified in numerous eukary-
otic transcription factors whose activity is rapidly in-NF-ATc, an inducibly expressed transcription factor,
duced upon cellular stimulation. This has been showncontrols gene expression in T lymphocytes and cardio-
in detail for the C-terminal TAD of inducible transcriptionmyocytes. We show here that the transcriptional co-
factor Elk-1/TCF-1, which contains multiple Ser/ThrProactivators CBP/p300 bind to and control the activity
phosphorylation motifs. Within seconds after cellularof the inducible N-terminal transactivation domain of
stimulation, extracellular signals are transmitted throughNF-ATc, TAD-A. Similar to the N terminal transactiva-
MAP kinase signaling cascades into the nucleus andtion domain of c-Jun, TAD-A is inducibly phosphory-
lead to the phosphorylation of several Ser/Thr residueslated, but this phosphorylation is dispensable for the
that are essential for the induction of Elk-1 and c-fosinteraction with CBP/p300. Constitutive active ver-
promoter activity (see Treisman, 1996, for a review).sions of c-Raf and Rac synergistically enhance the
In the transcriptional activation of the cAMP-inducibleCBP/p300-mediated increase of TAD-A activity, indi-
factor CREB, on the other hand, protein kinase A (PKA)cating the important role CBP/p300 plays in the inte-
mediates the specific phosphorylation of one Ser resi-
gration of T cell activation signals. Since a mutation
due, Ser-133, in its TAD. This is a prerequisite for the
of CBP abolishing HAT activity is almost as active as binding of CBP, a transcriptional cofactor that enhances
wild-type CBP in T cells, functions of CBP/p300 other transcription by CREB and numerous other transcription
than histone acetylation appear to control the NF-AT- factors (see Eckner, 1996; Torchia et al., 1998, for re-
dependent transcription in T cells. views).
In peripheral T lymphocytes, the two prominent mem-
bers of the NF-AT family, NF-ATp and NF-ATc, are highlyIntroduction
expressed and found to be the major components of
NF-AT complexes generated with binding sites from
The members of the NF-AT transcription factor family lymphokine promoters (Rao et al., 1997). Although NF-
contain a highly conserved DNA-binding domain that ATp and NF-ATc exhibit almost identical DNA binding
shares structural properties with those of Rel/NF-kB properties, they seem to differ markedly in their function:
factors and therefore is designated as Rel similarity do- whereas NF-ATp-deficient mice are born healthy and
main (RSD). Due to the high degree of sequence conser- show a mild lymphoproliferative disorder resulting in an
vation between their RSDs, NF-AT factors exert very increase in the number of peripheral T and B lympho-
similar DNA binding properties. Upon T cell activation, cytes and the size of lymphoid organs (Hodge et al.,
NF-AT factors bind in concert with AP-1 (Jun/Fos) fac- 1996; Xanthoudakis et al., 1996; Schuh et al., 1998),
tors to the promoters of numerous lymphokine and sur- NF-ATc-deficient mice die in utero around day 14 of
face receptor genes that contain multiple copies of the gestation. This is due to severe defects in the develop-
NF-AT ªcoreº motif T/A GGAAA (see Rao et al., 1997, for ment of cardiac valves and septa (de la Pompa et al.,
a review). 1998; Ranger et al., 1998a). In addition, cells of T cell
A further common property of NF-AT factors is their lineage generated in chimeric mice after injections of
inducible nuclear translocation, which is strictly con- RAG2/2 blastocysts with NF-ATc-deficient embryonic
trolled by calcineurin, a Ca11/calmodulin-dependent stem cells show a reduced proliferation and, in the pe-
riphery, a marked decrease in the synthesis of Th2 type
lymphokines (Marengere et al., 1998; Ranger et al.,§ To whom correspondence should be addressed (e-mail: path015@
mail.uni-wuerzburg.de). 1998b). Surprisingly, the synthesis of IL-2 was found to
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be unaffected both in NF-ATp- and NF-ATc-deficient T
cells.
The pleiotropic functions of NF-ATc in cardiomyo-
cytes and lymphocytes prompted us to investigate the
activation properties of NF-ATc in T lymphocytes. We
will show here that the transcriptional activity of NF-ATc
is controlled by a strong TAD, designated as TAD-A,
located near the N terminus in the three NF-ATc iso-
forms, A, B, and C, expressed in T cells (Chuvpilo et al.,
1999). Depending on the stimulus, a strong induction of
TAD-A from NF-ATc was observed, which, to a large
extent, is due to CBP/p300 that binds to and mediates
TAD-A activity.
CBP and p300 are highly related nuclear proteins that
have been shown to exert similar but not identical func-
tions during early embryogenesis of mouse (Yao et al.,
1998). They are cofactors for numerous transcription
factors by exerting adaptor functions, possess intrinsic
acetylase activity, and represent a platform for a large
number of potentially important associated proteins
(Eckner, 1996; Torchia et al., 1998). They are able to
acetylate all four core histones in their amino terminal
tails, thereby facilitating transcription (Bannister and
Kouzarides, 1996; Ogryzko et al., 1996). In addition to
histones, other components of the transcriptional ma-
Figure 1. p300 and CBP Enhance the Induction of the IL-2 Promoterchinery are also targets for CBP/p300, such as the basal
and the Distal NF-AT Site of IL-2 Promoter in Jurkat Cells
transcription factors TFIIE-b and TFIIF (Imhoff et al.,
(A) E1A inhibits and CBP/p300 enhance the induction of the IL-2
1997) and the tumor suppressor protein p53. For p53, promoter and distal NF-AT site. Luciferase reporter gene constructs
it has been shown that acetylation of its C-terminal DNA- driven by either the human IL-2 promoter (from 15 to 2499) or four
binding domain by CBP activates the sequence-specific copies of the distal NF-AT site were cotransfected with vectors
expressing E1A, p300, or CBP into Jurkat cells. After 6 hr, the cellsbinding to DNA (Gu and Roeder, 1997).
were induced by TPA/ionomycin (T 1 I) for 24 hr.We will show here that the N-terminal transactivation
(B) Interaction between NF-ATc and p300/CBP in vivo. 293 cellsdomain of NF-ATc, TAD-A, is bound and inducibly acti-
were transfected either with NF-ATc, p300-HA, or CBP-HA expres-
vated by CBP/p300. Although TAD-A becomes rapidly sion vectors alone or together as indicated. After 48 hr, cells were
phosphorylated at Ser-117 after activation of the MAP/ stimulated by T 1 I for 30 min, and p300-HA and CBP-HA proteins
Erk signaling cascade, this phosphorylation is neither were precipitated from whole cell protein extracts using a mono-
clonal antibody raised against the HA tag. Precipitated proteinsnecessary for the binding nor the activation of TAD-A
were fractionated, blotted, and immunodetected using anti-NF-ATcby CBP/p300. However, Raf/Erk- and Rac-mediated sig-
(upper panel), anti-p300 (lanes 1±4), or anti-CBP antibodies (lanesnals strongly stimulate the CBP/p300-mediated TAD-A
5±7) (lower panels).
activation. This provides an explanation for the activa-
tion of the distal IL-2 NF-AT/AP-1 site by multiple p21ras
effector pathways in T cells as published previously
a 3- to 4-fold increase of IL-2 promoter and NF-AT site(Genot et al., 1996). In addition, we show that a mutant
induction was observed when constructs expressingof CBP that lacks any detectable histone acetylase
p300 or CBP instead of E1A were cotransfected (Figuretransferase (HAT) activity still exerts a strong stimulatory
1A). Since E1A binds to both coactivators and inhibitseffect on TAD-A in T cells. These and further results
their activity (Eckner, 1996; Torchia et al., 1998), wesuggest that functions other than HAT activity, in partic-
conclude that the inhibitory effect of E1A on the IL-2ular the recruitment of additonal transcriptional cofac-
promoter and NF-AT site is due to the inhibition of en-tors, contribute to the stimulation of transcriptional acti-
dogenous CBP/p300-like activities that, therefore, ap-vation of NF-AT by CBP/p300.
pear to play an important role in NF-AT activation.
In order to assess whether p300 and CBP are able toResults
interact physically with NF-AT in vivo, carboxy-termi-
nally HA-tagged, full-length p300 or CBP proteins wereCBP/p300 Enhances the Induction of IL-2
expressed in human 293 cells alone or in the presencePromoter and NF-AT Site in T Cells
of NF-ATc. After the stimulation of cells with TPA andE1A is an inhibitor of IL-2 promoter induction in T cells.
ionomycin (T 1 I) for 2 hr, whole cell protein extractsWhen a DNA construct expressing the E1A 12 S RNA
were prepared and immunoprecipitations performedwas cotransfected together with an IL-2 promoter-
with a-HA antibodies followed by Western blotting usingdriven reporter gene into Jurkat T cells, the activity and
a-NF-ATc and a-p300/a-CBP antibodies. As shown ininduction of IL-2 promoter was inhibited to approxi-
Figure 1B, NF-ATc was specifically coimmunoprecipi-mately 20% of its normal activity (Figure 1A). The same
tated along with coexpressed p300-HA or CBP-HA, indi-inhibitory effect was also observed for the induction of
the distal NF-AT site from the IL-2 promoter. In contrast, cating an interaction between p300/CBP and NF-ATc.
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Figure 2. Identification and p300/CBP De-
pendency of the N-Terminal Transactivation
Domain, TAD-A, from NF-ATc
(A) Identification of TAD-A. Chimeric Gal4/
NF-ATc constructs (shown left, together with
a schematic structure of NF-ATc: SP, Ser/
Thr-rich regulatory domain of NF-ATc, lo-
cated between TAD-A and the Rel-similarity
domain [RSD]) were cotransfected into Jurkat
cells alone (middle) or along with a vector
expressing p300 (right panel) and a 5xGRE-
E1b-CAT construct driven by five Gal4 bind-
ing sites. In the middle panel, cells were also
induced by TPA for 20 hr. In a separate set
of experiments (shown below), the activity of
TAD-A was compared to that from c-Jun and
Elk-1 using a 5xGRE-E1b-luciferase reporter
gene construct. In the right panel, the Gal4
constructs were cotransfected with a 2-fold
excess of a p300 expression vector into Jur-
kat cells that were left uninduced.
(B) CBP and p300 enhance TAD-A activity.
Increasing amounts of vectors expressing
CBP or p300 were cotransfected into Jurkat
cells with constant amounts of a 5xGRE-E1b-
luciferase gene and vectors encoding Gal4/
TAD-A or Gal4 proteins.
(C) E1A suppresses TAD-A activity. Increas-
ing amounts of a vector expressing adenovi-
rus E1A protein were cotransfected into Jur-
kat cells with constant amounts of the
5xGRE-E1b-luciferase gene and a vector en-
coding Gal4/TAD-A. Six hours after transfec-
tion, the cells were either treated with TPA
for 20 hr or left untreated.
CBP/p300 Binds to and Activates activity (Figure 2C) that could be restored by overex-
pressing p300 (data not shown), we conclude that CBP/the Transactivation Domain
TAD-A of NF-ATc p300 is a cofactor that controls TAD-A activity. Similarly,
p300 enhanced markedly the TADc-Jun activity but ex-The distal NF-AT site of IL-2 promoter is bound by NF-
AT as well as AP-1 factors that are well known targets for erted only a very weak, if any, stimulatory effect on
TADElk-1 in unstimulated Jurkat cells (Figure 2A, lowerCBP/p300 and, therefore, for E1A-mediated repression.
Thus, the effects CBP/p300 and E1A exert on the activity panel). These findings agree well with the reported stim-
uli-dependent enhancement of Elk-1, but not c-Jun ac-of the IL-2 NF-AT/AP-1 site may be mediated through
AP-1. In order to elucidate whether NF-AT or AP-1 or tivity by CBP (Bannister et al., 1995; Janknecht and
Nordheim, 1996a).both factors are bound and regulated by CBP/p300,
we investigated the role CBP/p300 might play in the In order to investigate whether TAD-A interacts di-
rectly with CBP/p300, we performed binding assays withtransactivation of NF-ATc. As shown in Figure 2A (mid-
dle panel), for the activity of several Gal4/NF-ATc con- bacterially expressed GST/TAD-A and p300-HA proteins
transiently expressed in 293 cells. As shown in Figurestructs, NF-ATc harbors a strong TAD, designated as
TAD-A, near its N terminus spanning the aa residues 3A, GST/TAD-A was bound specifically to p300-HA im-
mobilized onto protein G sepharose beads precoated113 to 205. In Jurkat cells, the activity of TAD-A is stimu-
lated 3 (and sometimes 8)-fold by TPA but not by Ca11 with a-HA antibodies. In the same assay, the binding
of GST/NF-ATc1±108 but not GST/NF-ATc205±718 protein to(data not shown), a stimulus required for the nuclear
translocation of NF-AT. After TPA treatment, a very mod- p300-HA was detected, which correlates with the trans-
fection results indicating an 8-fold increase of the rela-erate increase was also observed for the activity of
N-terminal TAD5-89 from c-Jun. In contrast, a more than tively weak Gal4/1±108, but not of Gal4/205±716 activity
by p300 (Figure 2A, right panel). Thus, p300 interacts30-fold increase was found for a Gal4/Elk-1 protein har-
boring the C terminal TAD of Elk-1, which is known to with several portions of the N-terminal part of NF-ATc.
To address the question of whether these parts of NF-be a direct target for multiple MAP kinases (Yang et al.,
1998). Since increasing amounts of coexpressed p300 ATc contact one or several portions of p300, NF-ATc
was incubated with GST/p300 proteins spanning the aaor CBP enhanced TAD-A activity in a dose-dependent
manner (Figure 2B; see also 2A, right panel), and coex- residues from 1±596, 744±1571, and 1572±2370, respec-
tively. As shown in Figure 3B, NF-ATc was found to bindpressed E1A abolished any basal and inducible TAD-A
Immunity
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Figure 3. TAD-A Interacts with p300
(A) Interaction of p300 with N-terminal por-
tions of NF-ATc. p300-HA-tagged protein
was isolated from whole protein extracts of
transfected 293 cells by incubation with anti-
HA-coated protein G sepharose beads. The
beads were incubated with equalized amounts
of GST proteins (lanes 1±4, input protein; ar-
rowheads indicate the position of full-length
proteins) as indicated. After extensive wash-
ings, bound GST proteins were eluted and
fractionated on an SDS-PAA gel and immuno-
detected using a GST-specific antibody
(lanes 5±8).
(B) NF-ATc binds to multiple domains of p300.
Whole cell protein extracts were prepared
from 293 cells transfected with a cDNA vector
expressing NF-ATc. The proteins were incu-
bated with GST protein alone (lane 2) or chi-
meric GST-p300 proteins spanning the aa
residues 1±596, 744±1571, or 1572±2370, re-
spectively (lanes 3±5), and coupled to beads.
Proteins bound to the GST/p300 proteins
were eluted followed by electrophoresis and
immunodetection using an NF-ATc-specific
mAb. In lane 1, a part of the input protein
from 293 cells was fractionated. In lane 6,
GST-p3001572±2370 protein was incubated with
protein from untransfected 293 cells.
(C) TAD-A interacts with p300 in vivo. Mam-
malian two-hybrid system using 293 cells.
A 5xGRE-E1b-luciferase reporter gene was
cotransfected with vectors encoding Gal4/
TAD-AWT, TAD-A5xM, c-Jun5±89, or Elk-183±428 along with vectors encoding chimeric p300/VP16 genes. These code for p300WT, p300DC/H1 (lacking
the first C/H-rich domain of p300), p300DC/H3 (lacking the third C/H-rich domain and, therefore, the most prominent E1A binding site), and
p300/N, the N-terminal domain of p300.
to the N terminal p3001±596 and C terminal p3001572±2370 interaction with TAD-AWT and TAD-A5xM, it enhanced dra-
matically that mediated by TADc-Jun. Since the C/H3 do-peptides and, to a lesser extent, also to the central
p300744±1571 peptide but not to GST protein. This indicates main is a prominent E1A binding site (Eckner, 1996), this
might indicate that E1A suppresses through this site themultiple interactions of different affinity between N-ter-
minal domains of NF-ATc, including TAD-A, and several interaction of TADc-Jun with p300. However, sites of p300
in addition to the C/H3 domain appear to be more impor-domains of CBP/p300.
To verify the interactions between TAD-A and p300 tant for the E1A-mediated suppression of TAD-A activ-
ity. Deletion mutants of C/H1 and N-terminal domainsin vivo, we used the mammalian two-hybrid assay. Con-
structs encoding Gal4/TAD-AWT or Gal4/TAD-A5xM in of p300 were as strong as wild-type p300 to activate
Gal4-mediated transcription through interacting withwhich all Ser/Pro motifs were changed to Ala/Pro resi-
dues were transfected into 293 cells. They were coex- TADc-Jun but not TAD-A (Figure 3C). This correlates with
the strongest interaction identified in vitro between thepressed with fusion proteins consisting of wild-type
p300 and the strong TAD from VP16 (p300WT-VP16) or full-size NF-ATc and C-terminal part of p300 (Figure 3B,
lane 5) and again indicates multiple contacts betweenof several p300 mutants and TAD-VP16. Thus, in this
assay the transcriptional activation is mainly provided TAD-A and p300.
by the TAD-VP16 and reflects the strength of interaction
between TAD-A and various portions of p300. As con- MAP Kinase Stimulation Enhances
the CBP/p300-Mediatedtrols, Gal4 constructs were used encoding the TADs
from c-Jun and Elk-1. In all transfections, a distinct in- Activation of TAD-A
Several lines of evidence indicate a crucial role for thecrease of TAD-AWT, TAD-A5xM, and TADc-Jun activity was
detected in the unstimulated cells, whereas only a very small GTP binding proteins Ras and Rac in the T cell±
specific induction of NF-AT/AP-1 complex-mediatedweak, if any, increase in activity was observed for Elk-1.
This suggests a stimulus-independent interaction be- transcription (Genot et al., 1996). In order to test whether
Ras and Rac involved signaling pathways play a role intween TAD-A and p300, as described for CBP and c-Jun
(Bannister et al., 1995). However, the degree of the the activation of TAD-A in T cells, we investigated the
effect of activation of these signaling cascades onp300/VP16-mediated transactivation varied markedly
depending on the p300/VP16 and TAD proteins. Whereas TAD-A activity in transient transfections. Overexpres-
sion of wild-type Erk2 or Raf-BXB-CAAX, a constitutivethe deletion of the C/H3 domain in p300DC/H3-VP16 did
only slightly increase the activity mediated through the active version of c-Raf targeting its kinase domain to
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membranes (Whitehurst et al., 1995), led to a 2- to 5-fold transcription (Figure 4A, central panel). The loss of Ser-
117 phosphorylation did also not affect the interactionincrease of TAD-A activity in nonstimulated and TPA-
stimulated Jurkat cells, respectively. No increase was between TAD-A5xM and p300 in vivo (Figure 3C).
observed for the weak Gal4 activity. Similarly, overex-
pression of RacV12, a constitutive active version of Rac, Raf/Rac-Mediated Signals Synergize with CBP/p300
increased TAD-A activity 3- to 5-fold but did not affect to Induce TAD-A Activity in Jurkat T Cells
Gal4 activity (Figure 4A, left and right panels). PD098059, Next, we investigated whether Raf and Rac signals are
an efficient inhibitor of MEK activity, markedly impaired able to stimulate TAD-A in a concerted way with CBP/
the basal and TPA as well as Raf/Erk/Rac-mediated p300. Figure 5 shows that Raf-BXB-CAAX and RacV12
increase of TAD-A activity, while it did not affect Gal4 synergize to activate TAD-A. Indeed, this effect could
activity. These results suggest that signals critically in- strongly be enhanced by CBP/p300 in T cells. When
volved in T cell activation stimulate NF-ATc-mediated p300 was cotransfected with Raf- and Rac-expression
transcription via activation of TAD-A. vectors into Jurkat cells, relatively low concentrations
To show if TAD-A is a target of inducible phosporyla- of RacV12 and Raf-BXB-CAAX, unable to activate TAD-A
tion in vivo, we expressed GST/TAD-A protein in 293 by themselves, gave rise to a synergistic activation of
cells and measured its phosphorylation after TPA stimu- TAD-A as well as TAD-A5xM in untreated and TPA-stimu-
lation. TPA treatment for 30±45 min resulted in a rapid lated cells. The activation of both proteins was com-
phosphorylation of TAD-A in vivo (Figures 4D and 4G). pletely inhibited by PD098059 (Figure 5), indicating a
Phospho-amino acid analyses indicated the phosphory- crucial role for the Raf/Erk signaling cascade in the CBP/
lation of Ser, but not Thr or Tyr residues within TAD-A, p300-mediated activation of TAD-A. In addition, this
and in-gel kinase assays using GST/TAD-A as substrate suggests that not TAD-A itself but CBP/p300 and/or its
showed an inducible protein kinase activity at 42±44 associated factor(s) is/are direct target(s) of Ras- and
kDa, i.e., the size of Erk1 and 2 (data not shown). There- Rac- signaling cascades in T cells.
fore, we investigated whether the Erk kinases Erk1, 2,
and 3, JNK kinases (JNK1 and 2), and the cyclin-associ- HAT-Deficient CBP Efficiently Activates
ated kinases cdk2 and cdk4 immunoprecipitated from TAD-A in T Cells
protein extracts of stimulated Jurkat cells were able to The multiple functions of CBP/p300 prompted us to in-
phosphorylate TAD-A in vitro. TAD-A was found to be vestigate which of them were important for the inducible
an excellent substrate in vitro for Erk2 but not for JNK1/2 activation of TAD-A. To this end, we overexpressed
kinases (Figure 4E) or cdk2 and cdk4 (data not shown). Gal4/TAD-A in 293 cells along with increasing amounts
This correlates well with the suppression of TAD-A phos- of a mutated CBPF(1541)A lacking any HAT activity (see
phorylation in vivo by PD098059 (Figure 4G, compare Figure 6D). Compared to the same concentrations of
lanes 4 and 5). It also coincides with the lack of GST/ transfected CBPWT DNA, CBPF(1541)A was able to enhance
TAD-A phosphorylation in vivo after UV irradiation of TAD-A activity both in nontreated and TPA-treated 293
transfected 293 cells that, otherwise, leads to an effi- cells, in particular at a low concentration range. How-
cient activation of JNK kinases (data not shown). ever, when 200 ng of CBP expression vectors was used,
TAD-A harbors five potential SP motifs for the phos- CBPF(1541)A reached approximately 50% of the activation
phorylation by MAP kinases at the aa positions 117, observed for CBPWT (Figure 6A). These differences be-
151, 172, 199, and 203 (Figure 4C). Phosphopeptide tween both types of CBP were even more pronounced
mapping of TAD-A protein phosphorylated in vivo re- when tested on the distal IL-2 NF-AT/AP-1 site. In this
vealed the inducible phosphorylation on Ser residue 117 context, CBPF(1541)A led to a 2-fold and CBPWT to a 7- to
after TPA treatment (Figure 4F, 1±4). The same Ser resi- 10-fold increase of TAD-A activity in noninduced or T 1
due was also found to be phosphorylated in vitro using I±treated 293 cells transfected with an NF-ATc expres-
whole cell protein extract or Erk2 immunoprecipitated sion vector (Figure 6B). Surprisingly, in Jurkat cells
from TPA-treated Jurkat cells (data not shown). CBPF(1541)A appeared to be much stronger in stimulating
In order to elucidate a functional role of Ser-117 phos- TAD-A than in 293 cells reaching 80±90% of the activity
phorylation in TAD-A-mediated transcription, we trans- of CBPWT after TPA treatment (Figure 6C). This indicates
fected Jurkat cells with Gal4/TAD-A mutant proteins, distinct cell type-specific differences in the mode of
along with vectors overexpressing Erk2, Raf-BXB-CAAX, activation of TAD-A by CBP/p300.
and RacV12. Since a single mutation of Ser-117 to Ala
did not impair basal- or Raf- or Rac-induced transcrip- Discussion
tion (data not shown), TAD-A5xM protein was used in all
of the following experiments. TAD-A5xM was found to be In this study, we have shown that NF-ATc harbors a
expressed as strongly as TAD-A (Figure 4B) and neither strong transactivation domain, TAD-A, near its N termi-
phosphorylated in vivo (Figure 4G, compare lanes 6 and nus. TAD-A spans the aa residues 113±205 of NF-ATc
7 with 1±4) nor in vitro by Erk2 or a whole protein extract and is rapidly activated and phosphorylated upon T cell
from Jurkat cells (data not shown). However, to our sur- activation via MAP/Erk protein kinase-like signaling
prise, mutated TAD-A5xM was still able to enhance basal- pathways. However, the TPA-induced phosphorylation
and TPA-induced transcription, which was strongly en- on Ser-117 of TAD-A that we have detected appears to
hanced by overexpression of Raf-BXB-CAAX, Erk2, or play only a minor, if any, role in its inducible transcrip-
RacV12 and inhibited by PD098059, indicating a minor, if tional activation. In addition, this phosphorylation does
not seem to play a role in its binding to and activation byany, role of Ser-117 phosphorylation in TAD-A-mediated
Immunity
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Figure 4. The Inducible Phosphorylation of TAD-A Does Not Affect Its Transcriptional Activity
(A) Activation of MAP kinase pathways stimulates the transcriptional activity of TAD-AWT and TAD-A5xM but not basal Gal41±147 activity. Constructs
expressing chimeric Gal4/TAD-AWT, Gal4/TAD-A5xM, or Gal41±147 proteins were cotransfected into Jurkat cells with a 5xGRE-E1b-luciferase gene
alone or along with constructs expressing Erk2, Raf-BXB-CAAX, or RacV12. Six hours after transfection, the cells were either left uninduced
or induced by TPA for 20 hr in the absence or presence of PD098059 (30 mM) added 45 min before the start of TPA stimulation.
(B) Equal expression of Gal4/TAD-AWT and Gal4/TAD-A5xM proteins. Vectors expressing Gal4, Gal4/TAD-AWT, or Gal4/WT5xM proteins were
transfected into 293 cells. After 36 hr, nuclear proteins were extracted and incubated with a Gal4 binding site probe in EMSAs as described
(Schmitz and Baeuerle, 1994). In lane 1, protein was used from mock transfected cells; in lanes 2±10, protein from cells transfected with
vectors expressing either Gal41±147 (lanes 2±4), Gal4/TAD-AWT (lanes 5±7), or Gal4/TAD-A5xM protein (lanes 8±10) was used. For competition, a
100-fold excess of cold GRE site was added to lanes 3, 6, and 9, or a 100-fold excess of a cold NF-AT site was added in lanes 4, 7, and 10.
Lanes 1±4 were exposed for 12 hr and lanes 5±10 for 24 hr at a phosphoimager. The closed arrowhead indicates Gal4 protein/DNA complexes
and the open arrowhead the Gal4/TAD-AWT and Gal4/TAD-A5xM DNA complexes.
(C) Sequence of TAD-A. The SP motifs are indicated as white letters.
(D) TPA induces phosphorylation of TAD-A in vivo. A eukaryotic expression vector encoding GST-TAD-AWT was transfected into 293 cells.
Cells maintained in 32P-containing DMEM medium were stimulated with TPA for 30 or 45 min, proteins were extracted, and GST protein was
isolated by incubation with glutathione sepharose followed by electrophoresis, transfer to a nitrocellulose membrane, and detection by
CBP/p300-Dependent Induction of NF-ATc Activity
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Figure 5. p300 Integrates Raf- and Rac-
Mediated Signals for the Induction of TAD-A
Vectors expressing Gal4/TAD-AWT or Gal4/
TAD-A5xM were cotransfected into Jurkat cells
with a 5xGRE-E1b-luciferase reporter gene
alone or along with the indicated amounts
(mg) of Raf-BXB-CAAX, RacV12, or p300 ex-
pression vectors. MEK activity was inhibited
by 30 mM PD098059, which was added 45
min before TPA induction starting 6 hr after
transfection.
the transcriptional cofactor CBP/p300. In this respect, NF-ATp by calcineurin. In the same study, the homolo-
gous heptapeptide from NF-ATc containing Ser-117 wasTAD-A behaves very similarly to the N terminal TAD of
c-Jun but differs markedly from those of Elk-1 and shown to suppress the interaction of calcineurin with
an N terminal portion of NF-ATc (Aramburu et al., 1998).CREB. While the binding of CBP to TADc-Jun does not
need phosphorylation (Bannister et al., 1995), the PKA- Although Ser-117 in SPRIEIT appeared to be less impor-
tant than other aa residues for the interaction with cal-mediated phosphorylation of the Ser-133 residue of
CREB is a prerequisite for its binding to CBP (see, e.g., cineurin, it will be interesting to investigate whether its
phosphorylation will modulate the binding of calcineurinKwok et al., 1994). Stimuli-dependent phosphorylation
appears also to be necessary for the interaction between to TAD-A of nuclear NF-ATc and influence NF-AT activity
in T cells. While we did not find a role of Ser-117 phos-p300 and the TAD of Elk-1 in Jurkat and 293 cells. Neither
in the mammalian two-hybrid assay nor in cotransfec- phorylation for TAD-A binding to CBP/p300, the interac-
tion of this NF-ATc domain with other portions of thetions have we detected a TADElk-1/p300-mediated transcrip-
tional activation in unstimulated cells (see Figures 2A NF-ATc molecule and/or other factors could influence
NF-AT activity. Since both CBP/p300 and calcineurinand 3C). However, TPA stimulation of both types of cells
led to a very strong induction of TADElk-1 activity (Figure appear to contact the N-terminal TAD of NF-ATp (Gar-
cia-Rodriguez and Rao, 1998) and NF-ATc, it is likely2A) that was markedly enhanced by CBP/p300 (unpub-
lished data). The same stimulation led only to a moderate that calcineurin also controls the transactivation of NF-
AT factors, in addition to its role in nuclear translocationincrease of TAD-A and TADc-Jun activity, which, however,
was also strongly enhanced by CBP/p300. and DNA binding of NF-ATs (Rao et al., 1997).
A central finding of this study is the integration of Raf/The dispensibility of Ser-117 phosphorylation for the
inducible TAD-A activity does not necessarily mean that Erk and Rac signals through CBP/p300 in the activation
of TAD-A. Studying the induction conditions for the dis-it is without function in the control of NF-ATc activity.
For c-Jun, the inducible phosphorylation of N terminal tal NF-AT/AP-1 site of the IL-2 promoter in Jurkat cells,
Genot et al. (1996) came to the conclusion that activationTAD at the Ser residues 63 and 73 was shown to reduce
its ubiquitin-dependent degradation (Musti et al., 1997) of multiple MAP kinase pathways leads to the activation
of NF-AT in T cells. While these investigations could notand to be necessary for the protection of fibroblasts
against UV-induced apoptosis. However, it was found distinguish whether NF-AT itself or AP-1 (Jun/Fos) or
both factors were targets of these signaling cascades,to be dispensable for the cell cycle progression of fibro-
blasts (Wisdom et al., 1999). Moreover, a heptapeptide our results demonstrate that (1) NF-ATc itself is a target
of MAP kinase cascades, (2) CBP/p300 is a transcrip-of N-terminal peptide of NF-ATp, SPRIEIT, which is con-
served in NF-ATc, was recently shown to be required tional cofactor for NF-ATc, which (3) itself or through
associated proteins is targeted by MAP kinase signalingfor the effective recognition and dephosphorylation of
autoradiography (upper panel, 2 hr exposure). As loading control, GST proteins on the same membrane were immunodetected by incubation
with a GST-specific antibody (lower panel, 2 min exposure).
(E) Erk2 efficiently phosphorylates TAD-A in vitro. Erk and JNK kinases were immunoprecipitated from Jurkat cells treated for 30 min with
TPA and irradiated with UV (1 J/cm2) to stimulate JNK activity. The precipitates were used in in vitro protein kinase assays with bacterially
expressed GST-TAD-A and GST-cJun5±89 proteins or MBP as substrates.
(F) TAD-A is phosphorylated on Ser-117 in vivo. GST-TAD-A phosphorylated in vivo (see panel D) was subjected to trypsin digestion and two-
dimensional fractionation by electrophoresis at pH 1.9 and upscending thin layer chromatography followed by autoradiography (F1) (Boyle
et al., 1991). To identify the phospho-peptide chemically synthesized, phosphorylated peptides representing the aa residues 113±119 or
167±180 were separated under identical conditions alone (in F2 and F3, respectively) or together with the tryptic peptide from in vivo labeled
TAD-A (F4).
(G) MEK-dependent in vivo phosphorylation of TAD-AWT but not TAD-A5xM. Vectors expressing GST (lane 1), GST-TAD-AWT (lanes 2±5), or GST-
TAD-A5xM protein (lanes 6 and 7) were transfected into 293 cells. After incubation of cells with 32P, the cells were either left uninduced (lanes
2 and 6) or induced by TPA (lanes 1, 3±5, and 7) for 30 (lane 3) or 45 min (lanes 1, 4, 5, and 7). In lane 5, PD098059 was added 45 min before
induction. GST proteins were isolated, fractionated, and electroblotted, and phosphorylation was detected by autoradiography (upper panel).
The loading of GST proteins was checked using a GST-specific antibody (lower panel).
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site appeared to be dispensable for the interaction with
the Ets factors Sap-1a and Elk-1 (Janknecht and Nord-
heim, 1996a). Thus, MAP kinases seem to be able to
phosphorylate CBP/p300 directly, thereby enhancing its
transcriptional activity. Moreover, the S6 kinase pp90SRK,
an ultimate protein kinase of the Ras/Raf/Erk cascade,
was shown to bind to CBP and to be required for induc-
tion of Ras-responsive genes (Nakajima et al., 1996).
Taken together, the Ras/Raf/Erk cascade represents an
important signaling pathway through which extracellular
signals transferred through the T cell receptor are
guided to CBP/p300 and the IL-2 promoter.
It is presently unclear how Rac, alone or together with
Raf, stimulates the CBP/p300-mediated transactivation
of NF-ATc in T cells. Rac1 was shown to cooperate with
the protein tyrosine kinase Syk in the activation of JNK/
stress kinase cascades (Jacinto et al., 1998), but overex-
pression of JNK/SAP and p38 kinases did not efficiently
affect TAD-A activity alone or with CBP/p300 (A. A.,
unpublished data). Direct phosphorylation of NF-ATp
(Martinez-Martinez et al., 1997) and NF-AT4 by JNK has
been described that correlated with an inhibition of nu-
clear translocation of NF-AT4 (Chow et al., 1997). The
ability of JNK/SAP kinases to integrate TCR/CD3 with
CD28 costimulatory signals (Su et al., 1994) that increase
predominantly NF-kB/c-Rel activity (Bryan et al., 1994)
and the stability of IL-2 mRNA (Chen et al., 1998) lend
support to the conclusion that NF-AT sites themselves
are not the major targets of JNK/SAP protein kinases
in affecting IL-2 expression during T cell activation.
The activity of CBPF(1541)A mutant lacking HAT activity
Figure 6. CBP HAT Function Is Dispensable for TAD-A Activity in in enhancing TAD-A function in T cells suggests an im-
Jurkat Cells
portant role of CBP functions other than its HAT activity
(A) TAD-A activation in 293 cells. Vectors encoding Gal4/TAD-A in NF-AT stimulation. This is supported by the inability
and a 5xGRE-E1b-luciferase gene were cotransfected into 293 cells
to modulate histone H3 and 4 acetylation in Jurkat cellsalone or with increasing amounts of vectors expressing CBPWT or
with inducers or inhibitors, e.g., PD098059, of p300/CBPF(1541)A. Twenty hours later, the cells were either treated with TPA
or left uninduced as indicated. CBP-mediated NF-AT and TAD-A activity (A. A., unpub-
(B) Activation of an NF-AT site in 293 cells. Vectors encoding NF- lished data). For several transcription factors, it has been
ATc and a luciferase reporter gene controlled by four distal NF-AT demonstrated that CBP/p300 serves as a platform for
sites from the murine IL-2 promoter were cotransfected into 293 the assembly of further cofactors (Torchia et al., 1998).
cells alone or with vectors expressing CBPWT or CBPF(1541)A. Cells
When binding to nuclear hormone receptors, CBP/p300were either left uninduced or induced by T 1 I for 20 hr.
recruits several nuclear receptor coactivators (NCoAs),(C) TAD-A activation in Jurkat cells. Vectors encoding Gal4/TAD-A
or a 5xGRE-E1b luciferase gene were cotransfected into Jurkat cells such as NCoA-1, -2 and p/CIP, as well as p/CAF, a
alone or with increasing amounts of vectors expressing CBPWT or homolog of the Tetrahymena and yeast protein GCN5
CBPF(1541)A. that possesses intrinsic HAT activity (Bownell et al.,
(D) CBPF(1541)A lacks any HAT activity in vitro. Vectors encoding CBPWT 1996). Several, but not all, of these cofactors are also
or CBPF(1541)A were transfected into COS cells, precipitated using an
assembled to CBP/p300 when it binds to CREB andmAb against HA tag, and HAT activity was determined as described
Stat factors (see Torchia et al., 1998). It is very likelypreviously (Bannister and Kouzarides, 1996).
that the transcriptional activity of NF-AT factors is also
controlled by similar CBP/p300 supercomplexes. Thus,cascades to control NF-AT activity. MAP kinase cas-
we have to envisage that TCR-mediated signals modu-cades are known to be an essential component of signal-
late the phosphorylation state and, therefore, activity ofing machinery leading to T cell activation and lympho-
such cofactor platforms controlling NF-AT-dependentkine secretion (see Cantrell, 1996, for a review).
transcription.MAP kinases could target CBP/p300 by two distinct
but not necessarily exclusive mechanisms, i.e., phos-
phorylation of CBP/p300 itself and/or the assembly of Experimental Procedures
larger complexes consisting of further transcriptional
Cells and Transient DNA Transfectionscofactors. Several studies implicated CBP/p300 as a
Human Jurkat T leukemia cells were cultured in RPMI medium sup-target and direct substrate of Ser/Thr-specific protein
plemented with 5% FCS. They were transfected using the Superfectkinases, including MAP/Erk kinases (Janknecht and
transfection reagent (Qiagen) according to the manufacturer's pro-
Nordheim, 1996a, 1996b). C terminal phosphorylation of tocol. For stimulation, TPA (20 ng/ml) and ionomycin (0.5 mM) were
CBP by MAP kinases was shown to enhance its trans- added 6 hr after transfection, and luciferase activity was determined
20 hr later. Human 293 T embryonic kidney cells were grown inactivation potential, although phosphorylation of this
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DMEM medium supplemented with 10% FCS. They were transfected (1 J/cm2) Jurkat cells as described (Hibi et al., 1993). For in vitro
phosphorylation with immunoprecipitated protein kinases, 200 mgusing a standard calcium phosphate precipitation technique and
stimulated with 50 ng/ml TPA as indicated. Luciferase activities were of whole cell protein extract from induced Jurkat cells was incubated
with the indicated antibodies, and immune complexes were col-normalized on the basis of b-galactosidase activity of a cotrans-
fected RSV-driven b-galactosidase expression vector and protein lected onto protein G sepharose beads and, after extensive washing
with IP buffer, incubated with 5 mg of chimeric GST/TAD-A, GST/content.
c-Jun5±89, or myelin basic protein in 50 ml of kinase buffer (20 mM
HEPES [pH 7.8], 20 mM MgCl2, 0.5 mM DTT, 20 mM b-glycerophos-DNA Constructs
phate, 0.1 mM Na3VO4, 5 mM NaF, 0.1 mg/ml PMSF, 0.1 mg/mlVectors for the overexpression of Gal4/NF-ATc fusion proteins were
leupeptine, and 20 nM okadaic acid) containing 20 mM ATP and 5constructed on the basis of the RSV-LTR controlled Gal4 vector
mCi of 32P-g-ATP. After 20 min at 38C, the reaction was terminated bypABgal-linker (Baniahmad et al., 1992) encoding the aa residues
extensive washing of sepharose beads with ice-cold kinase buffer1±147 of the yeast factor Gal4. The following vectors were con-
without MgCl2. Phosphorylated proteins were eluted with 30 ml ofstructed. Gal4/TAD-A containing the aa residues 113±205 from NF-
1.5 3 Laemmli sample buffer and resolved on a 12.5% SDS-PAA gel.ATc: a PCR product encoding the first 301 aa of NF-ATc was cut
by NcoI and cloned as a blunt end fragment into the filled BamHI
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